daiichi-sankyo - Latest News on daiichi-sankyo | Read Breaking News on Zee News

Daiichi files plea in HC to vacate stay on Sun-Ranbaxy merger

Last Updated: Sunday, May 11, 2014, 16:19

Daiichi Sankyo, owner of Ranbaxy Laboratories Limited, has filed a petition in Andhra Pradesh High Court requesting it to vacate the 'status quo' order it issued earlier on Sun Pharma-Ranbaxy merger process.

Sun Pharma shares gain 7%, up 2nd day post Ranbaxy deal

Last Updated: Wednesday, April 09, 2014, 17:38

The scrip ended 6.91 percent up at Rs 627.80 on the BSE. During the day, it surged 8 percent to touch Rs 634.80. Ranbaxy stock rose 4.90 percent to Rs 467.

Ranbaxy hit by FDA product ban at 4th Indian plant; stock slumps 20%

Last Updated: Friday, January 24, 2014, 13:27

Ranbaxy shares fell as much as 19.43 percent on Friday to their lowest level in nearly four months.

Govt to review FDI policy in pharma sector on Monday

Last Updated: Friday, November 22, 2013, 20:20

Government will take up on Monday the issue of tightening FDI in existing pharmaceutical companies in the wake of concerns over multinationals taking over domestic drug makers.

Daiichi Sankyo's allegations false & baseless: Malvinder Singh

Last Updated: Friday, May 24, 2013, 09:04

Ranbaxy rebutted the allegations saying they did not misrepresent any facts or falsify any data.

Ranbaxy shares dive over 9% after Daiichi says misled over probes

Last Updated: Thursday, May 23, 2013, 12:57

Following the weakness in the stock, the market value of the company slipped by Rs 1,527 crore to Rs 16,708 crore.

Ranbaxy, Daiichi Sankyo to collaborate in Brazil to expand biz

Last Updated: Wednesday, April 17, 2013, 13:37

Drug major Ranbaxy Laboratories and its Japanese parent Daiichi Sankyo on Wednesday announced synergies in Brazil to expand their business in the Latin American nation.

Ranbaxy, Daiichi Sankyo to leverage synergies in Thailand

Last Updated: Wednesday, January 16, 2013, 13:50

Both the companies intend to integrate their business operations in Thailand.

Ranbaxy launches generic version of Evoxac in US market

Last Updated: Tuesday, October 09, 2012, 13:44

Ranbaxy Laboratories has launched generic cevimeline hydrochloride capsules, used in treating Sjogren's syndrome, in the US market under an agreement with Daiichi Sankyo Inc.

Daiichi Sankyo to sell Ranbaxy's products in Venezuela

Last Updated: Wednesday, June 20, 2012, 13:54

Japanese pharma major Daiichi Sankyo will start selling Ranbaxy Laboratories products in Venezuela under their hybrid business model, the two companies said on Wednesday.

Ranbaxy to sell Daiichi Sankyo's products in Italy

Last Updated: Tuesday, October 04, 2011, 17:55

Drug maker Ranbaxy Laboratories and its parent firm Daiichi Sankyo Tuesday said they have entered into a partnership to distribute the Japanese firm's products in Italy.

Ranbaxy Daiichi Sankyo to spend 200 mn yen on mobile clinics

Last Updated: Wednesday, August 31, 2011, 13:44

Drug major Ranbaxy on Wednesday said it will spend nearly 200 million yen (over Rs 10 crore) along with parent company Daiichi Sankyo over the next five years to sponsor mobile healthcare field clinics in India, Cameroon and Tanzania.